A M Schmidt
Impact in
- Clinical Biochemistry top 0.5%
- Advanced Glycation End Products research
- Neurology top 5%
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
-
- Advanced Glycation End Products research 8
-
- Natural Antidiabetic Agents Studies 3
- Diabetes Management and Research 1
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 1
- Co-authors
- D Stern (4 shared papers)Shi Du Yan (3 shared papers)S D Yan (3 shared papers)Osamu Hori (2 shared papers)Olivier Chappey (1 shared paper)M.-P. Wautier (1 shared paper)J Brett (1 shared paper)L Capron (1 shared paper)
- Journals
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (1 paper)European Journal of Clinical Investigation (1 paper)Diabetes (1 paper)Cellular and Molecular Life Sciences (1 paper)Journal of Clinical Investigation (1 paper)
- Partner nations
- United StatesFranceJapan
In The Last Decade
A M Schmidt
10 papers receiving 997 citations
Peers
Comparison fields: 5 of 79
- Clinical Biochemistry 565
- Neurology 139
- Physiology 364
- Endocrinology, Diabetes and Metabolism 222
- Nephrology 58
Countries citing papers authored by A M Schmidt
This map shows the geographic impact of A M Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A M Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A M Schmidt more than expected).
Fields of papers citing papers by A M Schmidt
This network shows the impact of papers produced by A M Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A M Schmidt. The network helps show where A M Schmidt may publish in the future.
Co-authors
The 25 scholars most cited alongside A M Schmidt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 298 | |
| 2 | 2002 | 249 | |
| 3 | 1998 | 201 | |
| 4 | 1996 | 66 | |
| 5 | 1997 | 60 | |
| 6 | 1999 | 57 | |
| 7 | 2000 | 50 | |
| 8 | 2001 | 35 | |
| 9 | 2013 | 3 | |
| 10 | 2003 | 1 |
About A M Schmidt
A M Schmidt is a scholar working on Clinical Biochemistry, Endocrinology, Diabetes and Metabolism, Physiology, Neurology and Molecular Biology, having authored 10 papers that have together received 1.0k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (8 papers), Natural Antidiabetic Agents Studies (3 papers), Alzheimer's disease research and treatments (2 papers), Neurological Disorders and Treatments (2 papers), Diabetes Management and Research (1 paper), Hyperglycemia and glycemic control in critically ill and hospitalized patients (1 paper), Epigenetics and DNA Methylation (1 paper) and Cholinesterase and Neurodegenerative Diseases (1 paper). The work is most often cited by research in Clinical Biochemistry (565 citations), Neurology (139 citations), Physiology (364 citations), Endocrinology, Diabetes and Metabolism (222 citations) and Nephrology (58 citations). A M Schmidt has collaborated with scholars based in United States, France and Japan. Frequent co-authors include D Stern, Shi Du Yan, S D Yan, Osamu Hori, Olivier Chappey, M.-P. Wautier, J Brett, L Capron, Clotilde Zoukourian and Jean‐Luc Wautier. Their work appears in journals such as Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, European Journal of Clinical Investigation, Diabetes, Cellular and Molecular Life Sciences and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.